← FDA Drug Approvals (Drugs@FDA)

RILUZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: KENTON · Approved 2019-12-09

Drug application

FDA Application #
ANDA206045
Application type
Abbreviated New Drug Application (Generic)
Brand name
RILUZOLE
Generic name
RILUZOLE
Active ingredients
RILUZOLE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
KENTON
Manufacturer
Florida Pharmaceutical Products, LLC
First approval
2019-12-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown